tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Nicole Germino, 14 are a BUY (87.5%), 2 are a HOLD (12.5%).
Analyst Nicole Germino works at TRUIST with a stock forecast success ratio of 33.33% fulfilled within 101.2 days on average.
Nicole Germino’s has documented 28 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SGMO, Sangamo Therapeutics at 07-Nov-2023.
Analyst best performing recommendations are on ASMB (ASSEMBLY BIOSCIENCES).
The best stock recommendation documented was for ASMB (ASSEMBLY BIOSCIENCES) at 10/19/2020. The price target of $55 was fulfilled within 137 days with a profit of $131.6 (70.53%) receiving and performance score of 5.15.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
2.5
18 days ago
0/1 (0%)
$-9.98 (-79.97%)
Buy
14
$-0.4 (-2.78%)
14
1 years 5 months 3 days ago
4/4 (100%)
$-1.84 (-11.62%)
328
Buy
11
$-3.4 (-23.61%)
12
1 years 5 months 26 days ago
5/5 (100%)
$-8.2 (-42.71%)
307
Buy
12
$-2.4 (-16.67%)
15
2 years 18 days ago
2/2 (100%)
$-12.72 (-51.46%)
502
Hold
8
2 years 11 months 9 days ago
0/3 (0%)
$3.55 (79.78%)
Which stock is Nicole Germino is most bullish on?
What Year was the first public recommendation made by Nicole Germino?
